Scroll Top

AI World Conference – MoneyBall Medicine Presentation

AI World Conference and Expo is focused on the state of the practice of artificial intelligence in the enterprise. Now in its third year, the 3-day conference and expo are designed for business and technology executives who want to learn about innovative implementations of AI in the enterprise. Enterprise organizations face conflicting priorities. Where do they turn to cut through the hype and determine how to prioritize AI strategies and technologies for their business? AI World is organized around this singular goal, enabling business leaders to learn how to use AI to build a competitive advantage, drive new business models and opportunities, reduce operational costs and accelerate your innovation efforts.

December 4th @ 2pm

Seaport World Trade Center
200 Seaport Boulevard
Boston, MA 02210

About Harry Glorikian

Harry Glorikian is an influential global business expert with more than three decades of experience building successful ventures in North America, Europe, Asia and the rest of the world. Harry is well known for achievements in life sciences, healthcare, diagnostics, healthcare IT and the convergence of these areas. He is a sought-after speaker, frequently quoted in the media, and regularly asked to assess, influence, and be part of innovative concepts and trends.

He is currently a General Partner at New Ventures Funds (NV). Before joining NV Funds, he served as an Entrepreneur In Residence to GE Ventures – New Business Creation Group. He currently serves on the board of GeneNews Ltd. He also serves on the advisory board of Evidation Health (a digital health startup launched with support from GE Ventures), and several other companies. He is also a co-founder and an advisory board member of DrawBridge Health (a revolutionary diagnostics startup launched with support from GE Ventures).

Harry holds an MBA from Boston University and a bachelor’s degree from San Francisco State University. Harry has addressed the NIH, Molecular Medicine Tri-Conference, World Theranostics Congress and other audiences, worldwide. He has authored numerous articles, appeared on CBS Evening News and been quoted regularly by Dow Jones, The Boston Globe, Los Angeles Times, London Independent, Medical Device Daily, Science Magazine, Genetic Engineering News and many others.